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Abstract 
An optical biosensor was developed to monitor the release of inflammatory cytokines by cells, aiming at the assessment of 
nanoparticle toxicity in vitro. Combined with optical detection, a label-free immunoassay allows quantifying the chemokine 
Interleukin 8 (IL-8) in cell culture medium, and discriminating between naive and stressed cells. Parallel detection of several 
cytokines involved in the inflammatory process provides a reliable analysis of the cellular immune response to stress caused by 
foreign agents like nanoparticles. Fluidic channels between the cell culture and the detection device leads to an integrated 
detection platform, allowing continuous monitoring of cellular events. 
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1. Introduction 
The need for nanoparticle toxicity assessment has become apparent with the increasing number of 
nanotechnology-based products on the market [1]. Most reliable assays currently rely on costly in vivo tests, whose 
number could be significantly decreased with in vitro screening assays. Promising in vitro methods for analyzing the 
cellular response rely on the detection of biomolecules released by cells into the cell culture medium. The presence 
of foreign agents, such as nanoparticles, in cell culture has been shown to induce cellular immune responses to 
stress, resulting in an increased production of several cytokines by cells, in particular Interleukin 8 (IL-8), IL-6 and 
the Monocyte Chemotactic Protein 1 (MCP-1) [2]. As a control experiment, the release of inflammatory cytokines 
can be induced by stimulation of the acute phase reaction, for example with the tumor necrosis factor-α (TNF-α). 
In this context, an analytical platform was developed to evaluate nanoparticle toxicity in vitro, looking at 
nanoparticle-induced immune responses from human cells. The device analyzes the composition of medium in real 
time, and relies on the quantification of relevant markers of cellular stress –IL-8, IL-6 and MCP-1– in the cell 
culture supernatant, monitoring immunoassays with the Wavelength Interrogated Optical Sensing (WIOS) 
instrument [3]. The detection unit was tested with supernatant solutions of cells exposed to TNF-α. 
 
* Corresponding author. Tel.: +41-32-720-5111; fax: +41-32-720-5740. 
 E-mail address: stephanie.pasche@csem.ch. 
1876-6196/09     © 2009 Published by Elsevier B.V. 
doi:10.1016/j.proche.2009.07.184
Procedia Chemistry 1 (2009) 738–741 
Open access under CC BY-NC-ND license.
2. Methods 
2.1. Wavelength Interrogated Optical Sensing (WIOS) 
WIOS (Dynetix AG, Switzerland ) uses the evanescent field to probe changes in the refractive index at the 
surface of a waveguide grating upon adsorption of biomolecules [3]. Tuning of the resonance wavelength allows 
real-time monitoring of the binding of unlabeled molecules on the waveguide grating surface (Fig. 1a). The surface 
of the chips is functionalized with a photopolymerizable dextran layer (OptoDex®, Arrayon Biotechnology SA, 
Switzerland), which allows covalent binding of biomolecules and at the same time prevents non-specific adsorption 
of biomolecules [4]. Eight distinct measurement zones on the chip allow immobilization of different capture 
antibodies on the surface, for the simultaneous detection of several analytes. A fluidic cell for in situ measurements 
allows monitoring biomolecule adsorption in real time, with a sensitivity of ~1 ng/cm2. 
2.2. Immunoassays 
IL-8, IL-6 and MCP-1 cytokines were detected with a sandwich immunoassay format, using specific antibodies 
(ImmunoTools, Germany).  Human IL-8 (clone JK8-1, Mouse IgG), human IL-6 (clone MQ2-13A5, Mouse IgG) 
and human MCP-1 (clone 2H5, Armenian Hamster IgG) (BioLegend, USA) specific capture antibodies were used. 
Cell supernatant samples (100 µl) were flown on top of the waveguide for 30 min in the stop-flow mode (multiple 
injections). Standard solutions of the cytokines were prepared in cell medium for calibration. After rinsing with 
PBS, polyclonal detection antibodies (rabbit IgG) (Peprotech, USA) were injected in the flow cell (30 µl, 20 µg/ml) 
for 30 min. After rinsing with PBS, rabbit specific IgG (α-rIgG) (JacksonImmunoResearch, England) (50 µl, 
50 µg/ml) was injected in the flow cell for 30 min as secondary antibody, in order to amplify the response signal. 
The variation of the WIOS signal before and after incubation with α-rIgG was reported for the different samples 
(Fig. 1b). The active surface was regenerated after the immunoassay, with 5 min exposure to 3M MgCl2, 0.75M 
HEPES containing 25% ethylene glycol (pH 3), thus enabling sequential measurements with a single chip. 
Enzyme-linked immunosorbent assays (ELISA) were used for reference measurements for IL-8, using 6 µg/ml of 
capture antibody (JK8-1) and 2 µg/ml of biotinylated detection antibody. The signal was developed using 3,3’5,5’-
Tetramethylbenzidin (TMB), stopping the reaction with 2M H2SO4, and analyzing  the optical density on a Tecan 
plate reader at 450 nm. 
2.3. Cell culture tests 
A549 human bronchial epithelial cells (ATCC, LGC Promochem, Germany) were cultured in RPMI 1640, 
supplemented with L-glutamine, penicillin/streptomycin, and 10% FCS (PAA Laboratories, Pasching, Austria), in 6-
well plates, using 5·105 cells per well. A549 cells were induced with 0, 20 or 300 ng/ml rhTNF-α (Immunotools, 
Germany), simulating the acute phase reaction [2]. Samples of the supernatant solution were collected after 6, 21 
and 48 hrs for analysis. 
Fig. 1. (a) WIOS instrument with waveguide chip and sensing principle [3]; (b) Monitoring of the sandwich immunoassay for IL-8 with WIOS.
a b 
 
739S. Pasche et al. / Procedia Chemistry 1 (2009) 738–741 
3. Results and discussion 
In a first stage, a sandwich immunoassay for the detection IL-8 was monitored in real time with the WIOS 
instrument, analyzing cell culture medium spiked with IL-8 concentrations between 0 and 10 ng/ml. This allowed 
establishing a calibration curve for IL-8. In a second stage, immunoreagents for the detection of IL-6 and MCP-1 
were implemented into the WIOS immunoassay, allowing simultaneous detection of three cytokines. The detection 
platform was tested for the analysis of IL-8 in cell supernatant samples of cells induced with TNF-α. Results 
obtained with WIOS were compared to values detected with ELISA.  
3.1. Immunoassay for the detection of IL-8 
Monitoring of the immunoassay for IL-8 consisted in adsorption of IL-8 on the capture antibody, recognition by 
the detection antibody (dAb), α-IL8, and amplification with the secondary antibody (Ab2), α-rIgG (Fig. 1b). 
Regeneration of the surface allowed desorbing all adsorbed species, while maintaining a high number of active 
capture antibodies on the chip surface. Up to ten regeneration cycles were performed on the chip, with a ~10% loss 
in response signal after each regeneration step (data not shown). The response signals for different IL-8 
concentrations in cell culture medium measured with WIOS allowed establishing a calibration curve (Fig. 2a). The 
response signal obtained with cell culture supernatant samples from naïve and TNF-α-induced cells was compared 
to the calibration curve, showing clear distinction between the two samples. The concentrations of IL-8 for the 
samples determined with WIOS (1.5 and 6.5 ng/ml) are close to those measured with ELISA (1.0 and 7.1 ng/ml). 
3.2. Multi-analyte immunoassay 
Simultaneous detection of three cytokines, IL-8, IL-6 and MCP-1, was achieved using a chip comprising 
different zones independently functionalized with the corresponding capture antibodies (Fig. 2b, inset). A mixture of 
the three detection antibodies was used for the detection step. No cross-reactivity was observed between the 
different species (Fig. 2b), and the response signal for a mixture containing the three cytokines was comparable to 
each signal acquired independently. Thus, the concentration of three cytokines could be detected in a single 
measurement, using only one sample.  
3.3. Tests in cell cultures 
The inflammatory reaction in cell cultures was monitored by quantifying the release of IL-8 by cells in the 
supernatant. A549 cells were exposed to different concentrations of the induction factor TNF-α, and the release of 
IL-8 by cells was measured in the cell culture medium after 6, 21, and 48 hrs of induction. The signal responses 
resulting from the immunoassay allowed discriminating between induced and uninduced cells, showing signals 
Fig. 2. (a) Calibration curve for IL-8 and quantification of two cell culture supernatant for naïve and TNF-α-induced cells; (b) Cross-reactivity 
between the different analytes and antibodies for the multi-analyte assay (IL-8, IL-6 and MCP-1) and design of the multi-analyte chip. 
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corresponding to different amounts of IL-8 in the medium (Fig. 3a). Comparison with ELISA analyses showed good 
correlation between the two techniques for low IL-8 concentrations (below 10 ng/ml) (Fig. 3b). The effect of 
nanoparticles on the cellular immune response could be assessed similarly, by monitoring cell cultures exposed to 
nanoparticles [2]. 
4. Conclusions 
An analytical device was designed for assessing the toxic effects from nanoparticles on cells in vitro. The cell 
immune response was evaluated by analyzing the cell culture medium, quantifying the concentration of cytokines 
secreted by the cells. Immunoassays for the detection of IL-8, IL-6 and MCP-1 were monitored in real time using an 
optical biosensor (WIOS), allowing parallel detection of the three cytokines in less than 2 hr. Cell supernatant 
samples were analyzed, and compared to standard ELISA assays, showing good correlation between both 
techniques. Analysis of cell cultures exposed to nanoparticles could be performed in the same way. Fluidic 
connections between the detection instrument and the cell culture vessel will allow continuously analyzing the cell 
culture medium, providing real-time information on the release of cytokines. Integration of a nanoparticle 
collecting/dispensing unit ahead of the cell culture will lead to an analytical platform for monitoring the toxic effects 
of nanoparticles on cells in vitro. This development offers a new tool towards a screening method for nanoparticle 
toxicity, thus limiting the number of costly in vivo experiments and impacting favourably on occupational health 
safety. 
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Fig. 3. (a) Analysis of cell supernatants with WIOS for sample exposed to 0, 20, 300 ng/ml TNF-α for 6, 21 and 48 hrs; (b) analysis of the same
samples with ELISA, showing the IL-8 concentration for each sample (the signal for 48 hr or 300 ng/ml TNF-α was saturated). 
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